Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary
Background: There is limited evidence on treating psoriasis patients with skin of color (SOC), contributing to disparities in accessing appropriate care for these patients. Objectives: This study aimed to develop consensus statements defining SOC terminology and addressing needs to optimize the clin...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328724001731 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527149741211648 |
|---|---|
| author | Geeta Yadav, MD Yvette Miller-Monthrope, MD Jaggi Rao, MD David N. Adam, MD Rachel N. Asiniwasis, MD Parbeer Grewal, MD Christina Han, MD Marissa Joseph, MD Richard G. Langley, MD Charles W. Lynde, MD Andrei Metelitsa, MD Loukia Mitsos, MD, PhD Boluwaji Ogunyemi, MD Kerri S. Purdy, MD Maxwell Sauder, MD Jensen Yeung, MD |
| author_facet | Geeta Yadav, MD Yvette Miller-Monthrope, MD Jaggi Rao, MD David N. Adam, MD Rachel N. Asiniwasis, MD Parbeer Grewal, MD Christina Han, MD Marissa Joseph, MD Richard G. Langley, MD Charles W. Lynde, MD Andrei Metelitsa, MD Loukia Mitsos, MD, PhD Boluwaji Ogunyemi, MD Kerri S. Purdy, MD Maxwell Sauder, MD Jensen Yeung, MD |
| author_sort | Geeta Yadav, MD |
| collection | DOAJ |
| description | Background: There is limited evidence on treating psoriasis patients with skin of color (SOC), contributing to disparities in accessing appropriate care for these patients. Objectives: This study aimed to develop consensus statements defining SOC terminology and addressing needs to optimize the clinical management of psoriasis in patients with SOC. Methods: Using the modified Delphi methodology 16 Canadian dermatologists with expertise in psoriasis developed consensus statements. Four core faculty members drove the content of the study, and 12 additional panel members were consulted to vote and provide consensus on the content produced by the core faculty. At a final meeting, the full panel revised and voted on the final consensus statements. Results: The exercise resulted in 11 consensus statements on SOC terminology, as well as 5 primary and 4 secondary statements on clinical presentation and differential diagnosis, and treatment guidelines based on evidence and expert opinion. Four additional consensus statements on current assessment tools and access to care were developed based solely on expert opinion. Limitations: The available evidence was limited, low quality, and inappropriate for formal quality assessment. Conclusions: The consensus statements developed in this study may provide valuable guidance to the dermatology community treating psoriasis patients with SOC. |
| format | Article |
| id | doaj-art-14f3b710b1c24faaaa391d095be15142 |
| institution | Kabale University |
| issn | 2666-3287 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD International |
| spelling | doaj-art-14f3b710b1c24faaaa391d095be151422025-01-16T04:29:17ZengElsevierJAAD International2666-32872025-04-01191220Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule SummaryGeeta Yadav, MD0Yvette Miller-Monthrope, MD1Jaggi Rao, MD2David N. Adam, MD3Rachel N. Asiniwasis, MD4Parbeer Grewal, MD5Christina Han, MD6Marissa Joseph, MD7Richard G. Langley, MD8Charles W. Lynde, MD9Andrei Metelitsa, MD10Loukia Mitsos, MD, PhD11Boluwaji Ogunyemi, MD12Kerri S. Purdy, MD13Maxwell Sauder, MD14Jensen Yeung, MD15Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; FACET Dermatology, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Correspondence to: Geeta Yadav, MD, FACET Dermatology, 710 Kingston Rd, Toronto, Ontario M4E 1R7, Canada.Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaProbity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDivision of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Baywood Dermatology & CCA Medical Research, Ajax, Ontario, CanadaOrigins Dermatology Centre, Regina, Saskatchewan, Canada; Division of Dermatology, University of Saskatchewan, Regina, Saskatchewan, CanadaDivision of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Rejuvenation Dermatology, Edmonton, Alberta, CanadaDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, CanadaDivision of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Section of Dermatology, Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Dermatology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDivision of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Lynde Institute for Dermatology, Markham, Ontario, CanadaProbity Medical Research, Waterloo, Ontario, Canada; Beacon Dermatology, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, CanadaProtoderma, Pierrefonds, Quebec, CanadaDiscipline of Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, CanadaDivision of Dermatology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDivision of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, CanadaDivision of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, CanadaBackground: There is limited evidence on treating psoriasis patients with skin of color (SOC), contributing to disparities in accessing appropriate care for these patients. Objectives: This study aimed to develop consensus statements defining SOC terminology and addressing needs to optimize the clinical management of psoriasis in patients with SOC. Methods: Using the modified Delphi methodology 16 Canadian dermatologists with expertise in psoriasis developed consensus statements. Four core faculty members drove the content of the study, and 12 additional panel members were consulted to vote and provide consensus on the content produced by the core faculty. At a final meeting, the full panel revised and voted on the final consensus statements. Results: The exercise resulted in 11 consensus statements on SOC terminology, as well as 5 primary and 4 secondary statements on clinical presentation and differential diagnosis, and treatment guidelines based on evidence and expert opinion. Four additional consensus statements on current assessment tools and access to care were developed based solely on expert opinion. Limitations: The available evidence was limited, low quality, and inappropriate for formal quality assessment. Conclusions: The consensus statements developed in this study may provide valuable guidance to the dermatology community treating psoriasis patients with SOC.http://www.sciencedirect.com/science/article/pii/S2666328724001731Canadian Delphi consensusdisparities in psoriasis managementdiversityequitypsoriasisskin of color |
| spellingShingle | Geeta Yadav, MD Yvette Miller-Monthrope, MD Jaggi Rao, MD David N. Adam, MD Rachel N. Asiniwasis, MD Parbeer Grewal, MD Christina Han, MD Marissa Joseph, MD Richard G. Langley, MD Charles W. Lynde, MD Andrei Metelitsa, MD Loukia Mitsos, MD, PhD Boluwaji Ogunyemi, MD Kerri S. Purdy, MD Maxwell Sauder, MD Jensen Yeung, MD Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary JAAD International Canadian Delphi consensus disparities in psoriasis management diversity equity psoriasis skin of color |
| title | Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary |
| title_full | Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary |
| title_fullStr | Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary |
| title_full_unstemmed | Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary |
| title_short | Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensusCapsule Summary |
| title_sort | optimizing the management of psoriasis in patients with skin of color a canadian delphi consensuscapsule summary |
| topic | Canadian Delphi consensus disparities in psoriasis management diversity equity psoriasis skin of color |
| url | http://www.sciencedirect.com/science/article/pii/S2666328724001731 |
| work_keys_str_mv | AT geetayadavmd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT yvettemillermonthropemd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT jaggiraomd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT davidnadammd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT rachelnasiniwasismd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT parbeergrewalmd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT christinahanmd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT marissajosephmd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT richardglangleymd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT charleswlyndemd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT andreimetelitsamd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT loukiamitsosmdphd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT boluwajiogunyemimd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT kerrispurdymd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT maxwellsaudermd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary AT jensenyeungmd optimizingthemanagementofpsoriasisinpatientswithskinofcoloracanadiandelphiconsensuscapsulesummary |